Science Current Events | Science News |

Cancer 'turns off' important immune cells, complicating experimental vaccine therapies

August 31, 2012

New research published in the Journal of Leukocyte Biology suggests monocyte-derived dendritic cells may not be as effective in inducing desired immune responses as previously expected

Bethesda, MD-A research report published in the September 2012 issue of the Journal of Leukocyte Biology offers a possible explanation of why some cancer vaccines are not as effective as hoped, while at the same time identifies a new therapeutic strategy for treating autoimmune problems. In the report, scientists suggest that cancer, even in the very early stages, produces a negative immune response from dendritic cells, which prevent lymphocytes from working against the disease. Although problematic for cancer treatment, these flawed dendritic cells could be valuable therapeutic tools for preventing the immune system from attacking what it should not, as is the case with autoimmune disorders and organ transplants.

"Immunotherapy of cancer has been an elusive research target that, though promising, never seems to 'get there,'" said José Alexandre M. Barbuto, Ph.D., from the Laboratory of Tumor Immunology, Department of Immunology, Institute of Biomedical Sciences at the University of São Paulo, in São Paulo, Brazil. "This study helps us to better understand the mechanisms by which tumors avoid immune recognition and rejection and may, therefore, teach us how to actually engage effectively the immune system in the fight against tumors, thus achieving much better clinical responses and, consequently, quality of life, in our therapeutic approaches."

To make this discovery, researchers obtained a small sample of blood from breast cancer patients, and from healthy volunteers. The blood cells were then separated and induced to become dendritic cells. Researchers then used these laboratory-generated dendritic cells to induce responses from other immune system cells, namely lymphocytes. While dendritic cells from the healthy donors induced vigorous lymphocytic responses, dendritic cells from cancer patients induced mainly the activation of a specific type of lymphocyte, a regulatory lymphocyte that works as a "brake" for other types of lymphocytes.

"Understanding why the immune system does not recognize and eliminate cancer is critical to developing effective immunotherapies to fight the disease," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology. "Immunologists have been trying to unravel the answer to this question for decades and have realized that the problem is both on the immune system side, and because cancer cells appear to actively 'fly under the radar' avoiding immune system detection. This article offers insights into the underlying mechanisms regulating a key immune cell type, the dendritic cell, involved in initiating anti-tumor responses."

Federation of American Societies for Experimental Biology

Related Dendritic Cells Current Events and Dendritic Cells News Articles

Differences in individuals' immune responses linked to flu vaccine effectiveness
For the first time, scientists have identified how differences in individuals' immune responses might be linked to the effectiveness of the seasonal influenza vaccination programme. The findings are published in the journal, Immunology.

Long-term survival achieved in metastatic melanoma with personalized vaccine
Two patients with melanoma that had spread to the liver survived for at least 8.5 and 12 years after resection of the hepatic tumor and treatment with patient-specific immunotherapeutic vaccines.

Salt-inducible kinases may have therapeutic potential for autoimmune diseases
A new research report appearing in the May 2016 issue of the Journal of Leukocyte Biology, suggests that specific enzymes, called "salt-inducible kinases," may be able to help curb runaway inflammation associated with autoimmune diseases like Crohn's disease, arthritis, and psoriasis.

Simpler technique yields antibodies to a range of infectious agents
Researchers hope to develop vaccines, therapeutics and new diagnostic tests for a broad range of diseases.

Adenosine deaminase may help the immune system fight HIV on its own
New research findings published in the February 2016 issue of the Journal of Leukocyte Biology, suggest that a new therapeutic strategy for HIV may already be available by repurposing an existing prescription drug.

Optogenetic technology developed at UMMS uses light to trigger immunotherapy
A new optogenetic technology developed by scientists at the University of Massachusetts Medical School and Texas A&M Health Science Center Institute of Biosciences & Technology, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice.

Potential therapeutic targets identified for multiple sclerosis
Treatment of multiple sclerosis (MS) and other inflammatory diseases may benefit by new findings from a study that identified potential therapeutic targets for a devastating disease striking some 2.3 million people worldwide.

Commensal bacteria regulate immune cells in lungs to produce proteins for host defense
Microbiota--the trillions of bacteria that co-exist in the body--regulate the ability of lung dendritic cells to generate immune responses, according to a study led by researchers from the Icahn School of Medicine at Mount Sinai, published online in the Journal of Experimental Medicine.

Early childhood exposure to farm animals and pets modifies immunological responses
Exposure to farm animals in early childhood modifies the key allergy-related immunological mechanisms, shows a recent study from the University of Eastern Finland. The study provides new insight into the role of dendritic cells and cytokine production in particular.

Suspect cells not guilty after all in late-stage lupus
For years, biomedical researchers have suspected that a specific set of immune cells are responsible for causing disease in lupus patients, but until now they haven't known for sure one way or the other.
More Dendritic Cells Current Events and Dendritic Cells News Articles

Dendritic Cell Protocols (Methods in Molecular Biology)

Dendritic Cell Protocols (Methods in Molecular Biology)
by Elodie Segura (Editor), Nobuyuki Onai (Editor)

The third edition of this volume is aimed at providing both beginners and more experienced researchers a choice of methods to isolate and analyze dendritic cells(DC). An introductory review provides an overview of recent advances in the characterization of DC subsets in mouse and human. While additional chapters provide methods to culture human and mouse dendritic cells, protocols for the isolation of dendritic cells, the isolation of dendritic cell progenitors from mouse, and the purification of dendritic cells from human blood. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on...

Dendritic Cell Protocols (Methods in Molecular Biology)

Dendritic Cell Protocols (Methods in Molecular Biology)
by Shalin H. Naik (Editor)

Given the vital importance of immune system research, the gathering of clear, consistent, and informative protocols involving the study of dendritic cells is paramount. Bringing the popular first edition fully up to date, Dendritic Cell Protocols, Second Edition presents protocols from experts in the field that cover the basics and more complex forays into the exploration of DC development and function, both in mice and humans. The first section of the volume involving humans explores topics such as the isolation of blood DC subtypes, primary skin Langerhans cells, and the generation of gene-manipulated human DCs with the inclusion of more clinically relevant methods as well, while the second section involving rodent models delves into DC and precursor generation in vitro, isolation ex...

Dendritic Cells in Cancer

Dendritic Cells in Cancer
by Michael R Shurin (Editor), Russell D. Salter (Editor)

It covers all aspects of DC generation, function, survival and antitumor activity in the tumor environment both in vivo and in experimental in vitro systems. The goal in focusing on a spectrum of issues related to DC in cancer is to provide an extensive and expansive review rather than a collection of independent analyses from different authors. Specific topics to be covered include analysis of DC behavior in the tumor microenvironment, including endogenous and exogenous DC, multiple DC populations, molecular pathways responsible for DC dysfunction, tumor-derived factors altering DC polarization and activation, mechanisms of DC alterations, and the role of DC in tumor escape from immune recognition and elimination. Furthermore, additional chapters provide extensive analysis of the...

Dendritic cell in chronic obstructive pulmonary disease

Dendritic cell in chronic obstructive pulmonary disease
by Nuha Alkhattabi (Author)

Chronic obstructive pulmonary disease (COPD) is an airway disorder characterized by airway obstructions that are not fully reversible. The main cause of COPD is cigarette smoking; however, not all smokers are susceptible, as immunological responses have a major role in the development of the disease. In particular, dendritic cells (DCs) play an important role in the development of COPD; however, their role is still not fully understood. In this booklet I am highlighting the possible role of DCs in the disease progress in studies that used human, animal or cell culture models.

Dendritic cells for the treatment of autoimmune disease: -Rheumatoid arthritis-

Dendritic cells for the treatment of autoimmune disease: -Rheumatoid arthritis-
by Dae-Seog Lim (Author), Jun-Ho Lee (Author), Sei-Hee Byun (Author)

A number of autoimmune disease models have been used to examine the anti-inflammatory and immunosuppressive effects of tolerogenic dendritic cells (tDCs). The aim of the present study was to investigate whether rosiglitazone-mediated DC (Rosi-DC) therapy suppressed arthritis in a collagen-induced arthritis (CIA) mouse model. The results presented herein show that type II collagen-pulsed Rosi-DCs ameliorate the inflammation associated with CIA via the induction of Treg cell population. These results suggest that rosiglitazone-mediated DCs hold promise as a novel therapeutic strategy for RA.

Dendritic Cell-based Vaccine Strategies in MTB Infection: Mathematical Modeling of Dendritic Cell-Based Vaccination Strategies in Mycobacterium Tuberculosis Infection

Dendritic Cell-based Vaccine Strategies in MTB Infection: Mathematical Modeling of Dendritic Cell-Based Vaccination Strategies in Mycobacterium Tuberculosis Infection
by Nothabo Dube (Author), Winston Garira (Author), Gesham Magombedze (Author)

Dendritic cells (DCs) are known to play a pivotal role in linking the innate and adaptiveimmune mechanisms. We study the effects of a Dendritic cell based vaccine in the fightagainst Mycobacterium tuberculosis. First a model without immune response is considered, then a model with T and CTL mechanisms, then a model with T,CTL and Dendritic cells and finally a model with a dendritic cell-based vaccine. From our model analysis, we conclude that the introduction of a cell-based vaccine can go a long way towards the effective control of the Mtb infection.

Dendritic Cells: Biophysics, Tumor Microenvironment and Chinese Traditional Medicine (SpringerBriefs in Biochemistry and Molecular Biology)

Dendritic Cells: Biophysics, Tumor Microenvironment and Chinese Traditional Medicine (SpringerBriefs in Biochemistry and Molecular Biology)
by Zhu Zeng (Author), Xiaofeng Xu (Author), Dan Chen (Author)

In this book, the authors discuss the biophysical characteristics of Dendritic cells (DCs) at various differentiation stages and in tumor microenvironments in detail. A type of Chinese traditional herb, which can improve the biophysical and microrheological properties of DCs, is also introduced. DCs are potent and specialized antigen-presenting cells that play a crucial role in initiating and amplifying both the innate and adaptive immune responses. The biophysical and microrheological characteristics of DCs are important for their motility and normal immune function. In tumor microenvironments, the motility and immune functions of DCs are impaired, but the mechanisms are largely unknown. This book offers researchers a comprehensive and deep insight into the biophysical characteristics of...

Dendritic Cells: Biology and Clinical Applications

Dendritic Cells: Biology and Clinical Applications
by Academic Press

Dendritic Cells, 2nd Edition is the new edition of the extremely successful book published in 1998. With the volume of literature on dendritic cells doubling every year, it is almost impossible to keep up. This book provides the most up-to-date synthesis of the literature, written by the very best authors. It is essential reading for any scientist working in immunology, cell biology, infectious diseases, cancer, transplantation, genetic engineering, or the pharmaceutical/biotechnology industry.

* An entirely new section on DC biology is included in this edition. Also new to this edition are chapters on:
* Imaging
* Interaction of dendritic cells with viruses
* Dendritic cells and dendrikines, chemokines and the endothelium
* Molecules expressed in dendritic...

Cancer Immunotherapy: Chapter 17. Adoptive T-cell Therapy: Engineering T-cell Receptors

Cancer Immunotherapy: Chapter 17. Adoptive T-cell Therapy: Engineering T-cell Receptors
by Academic Press

Adoptive cell therapy for cancer using tumor antigen-reactive cytotoxic lymphocytes or with tumor infiltrating lymphocytes has been shown to be a potent therapy for metastatic cancer. The generation of tumor-reactive T cells is not always possible in all of the patients. To overcome this limitation, investigators can now insert highly avid T-cell receptors (TCR) into T cells that can recognize tumor antigens. Genetic engineering of TCR genes into normal T cells is a powerful new strategy to generate large numbers of defined antigen-specific cells for therapeutic application. This approach has evolved beyond experimental stage into a clinical reality. The feasibility of TCR engineered T cells has been shown to be an effective clinical strategy resulting in the regression of established...

Molecular Modifications and Functional Conditioning of Dendritic Cells (DC) for DC-based Tumor Vaccines

Molecular Modifications and Functional Conditioning of Dendritic Cells (DC) for DC-based Tumor Vaccines
by Kar-wing To (Author), 杜嘉詠 (Creator)

This dissertation, "Molecular Modifications and Functional Conditioning of Dendritic Cells (DC) for DC-based Tumor Vaccines" by Kar-wing, To, 杜嘉詠, was obtained from The University of Hong Kong (Pokfulam, Hong Kong) and is being sold pursuant to Creative Commons: Attribution 3.0 Hong Kong License. The content of this dissertation has not been altered in any way. We have altered the formatting in order to facilitate the ease of printing and reading of the dissertation. All rights not granted by the above license are retained by the author.


Abstract of thesis entitled

Molecular Modifications and Functional Conditioning of Dendritic Cells (DC) for DC-based Tumor Vaccines

Submitted by Kar-wing To

for the degree of Doctor of Philosophy The...

© 2017